Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Neuronetics, Inc. (STIM)
USD1.95
+0.18 (+9.89%)
US NASDAQ Healthcare Medical - Diagnostics & Research
Address
3222 Phoenixville Pike 19355
Malvern, PA, US
Malvern, PA, US
CEO
Daniel L. Reuvers
Website
neurostar.com
IPO
2018-06-28
CIK 1227636 ISIN US64131A1051
Description
Neuronetics, Inc. functions as a medical technology enterprise with commercialized products, specializing in the creation, enhancement, and global distribution of solutions for individuals experiencing neurohealth conditions, both within the U.S. and abroad. The company's flagship product is the NeuroStar Advanced Therapy System, an in-office, non-surgical, and non-pharmaceutical treatment option available for adult patients diagnosed with major depressive disorder. This sophisticated system utilizes transcranial magnetic stimulation (TMS) to generate a pulsed magnetic field, similar in strength to an MRI, which subsequently induces electrical currents. These currents are specifically engineered to activate brain areas that are key to mood regulation. Neuronetics distributes its offerings directly to psychiatrists through its dedicated sales and client support personnel. Established in 2001, the company's corporate headquarters are situated in Malvern, Pennsylvania.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD1.95
+0.18 (+9.89%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
1.04
Float Shares
36.03M
Free Float %
51.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -15.61% | -33.51% | -5.93% | -19.62% | -41.20% | -7.97% | -69.32% | -54.32% | -90.62% | -95.43% | -95.43% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (7 ratings, all time)
Buy
Price Targets & DCF
Current price
1.95
Low
8.00
+311.3%
Consensus
8.00
+311.3%
Median
8.00
+311.3%
High
8.00
+311.3%
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | — | — |
| All Time | 2 |
8.00
+311.3%
|
Quality scores
Altman Z-Score
-4.05
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
5 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Diagnostics & Research: +7.9%+99.2% ★ Q1'26: +7.8% (vs Q1'25)
-
EPS growth Medical - Diagnostics & Research: +30.8%+57.3% ★ Q1'26: +23.8% (vs Q1'25)
-
FCF margin FCF growth · Medical - Diagnostics & Research: +32.2%-20.5% Q1'26: -27.9% (vs Q1'25)
-
EBIT margin Medical - Diagnostics & Research: +9.6%-21.1% Q1'26: -26.1% (vs Q1'25)
-
ROIC Medical - Diagnostics & Research: +5.2%-38.3% Q1'26: -128.8% (vs Q1'25)
-
Share dilution Medical - Diagnostics & Research: 0.0%+107.8% Q1'26: +13.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Diagnostics & Research: -0.13×-3.23× Q1'26: -0.73× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 2 EPS Ana. |
Dec 2027 2 Rev. Ana. 2 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
52.78M
est: 52.03M (+1.4%)
|
62.66M
est: 62.24M (+0.7%)
|
49.24M
est: 48.07M (+2.5%)
|
55.31M
est: 54.37M (+1.7%)
|
65.21M
est: 63.82M (+2.2%)
|
71.35M
est: 72.07M (-1.0%)
|
74.89M
est: 72.03M (+4.0%)
|
149.16M
est: 148.09M (+0.7%)
|
162.15M
159.53M – 164.41M
+9.5% YoY
|
181.34M
178.41M – 183.87M
+11.8% YoY
|
213.20M
209.75M – 216.17M
+17.6% YoY
|
237.10M
233.27M – 240.40M
+11.2% YoY
|
263.00M
258.75M – 266.66M
+10.9% YoY
|
| EBITDA |
-19.53M
est: -23.71M (+17.6%)
|
-27.19M
est: -28.36M (+4.1%)
|
-25.89M
est: -21.90M (-18.2%)
|
-26.81M
est: -24.78M (-8.2%)
|
-31.96M
est: -29.09M (-9.9%)
|
-22.76M
est: -27.97M (+18.6%)
|
-34.37M
est: -27.95M (-22.9%)
|
-27.97M
est: -57.47M (+51.3%)
|
-62.93M
-63.80M – -61.91M
-9.5% YoY
|
-70.37M
-71.35M – -69.24M
-11.8% YoY
|
-82.74M
-83.89M – -81.40M
-17.6% YoY
|
-92.01M
-93.29M – -90.52M
-11.2% YoY
|
-102.06M
-103.48M – -100.41M
-10.9% YoY
|
| EBIT |
-20.41M
est: -24.95M (+18.2%)
|
-28.26M
est: -29.85M (+5.3%)
|
-26.83M
est: -23.05M (-16.4%)
|
-27.87M
est: -26.08M (-6.9%)
|
-33.61M
est: -30.61M (-9.8%)
|
-24.77M
est: -29.75M (+16.7%)
|
-36.44M
est: -29.73M (-22.6%)
|
-31.44M
est: -61.12M (+48.6%)
|
-66.93M
-67.86M – -65.85M
-9.5% YoY
|
-74.85M
-75.89M – -73.64M
-11.8% YoY
|
-88.00M
-89.23M – -86.58M
-17.6% YoY
|
-97.87M
-99.23M – -96.28M
-11.2% YoY
|
-108.56M
-110.07M – -106.80M
-10.9% YoY
|
| Net Income |
-24.10M
est: -259.96M (+90.7%)
|
-29.04M
est: -51.21M (+43.3%)
|
-27.45M
est: -47.79M (+42.6%)
|
-31.19M
est: -39.30M (+20.6%)
|
-37.16M
est: -46.23M (+19.6%)
|
-30.19M
est: -72.79M (+58.5%)
|
-43.71M
est: -83.76M (+47.8%)
|
-39.00M
est: -39.18M (+0.5%)
|
-30.00M
-30.58M – -29.41M
+23.4% YoY
|
-19.94M
-20.33M – -19.55M
+33.5% YoY
|
-11.85M
-12.09M – -11.62M
+40.5% YoY
|
-5.28M
-5.37M – -5.17M
+55.5% YoY
|
-3.30M
-3.36M – -3.23M
+37.5% YoY
|
| SGA |
51.93M
est: 55.85M (-7.0%)
|
60.45M
est: 66.81M (-9.5%)
|
50.80M
est: 51.60M (-1.6%)
|
63.30M
est: 58.37M (+8.4%)
|
75.50M
est: 68.52M (+10.2%)
|
72.74M
est: 71.88M (+1.2%)
|
75.95M
est: 71.85M (+5.7%)
|
97.16M
est: 147.71M (-34.2%)
|
161.74M
159.13M – 164.00M
+9.5% YoY
|
180.89M
177.96M – 183.41M
+11.8% YoY
|
212.66M
209.22M – 215.63M
+17.6% YoY
|
236.50M
232.68M – 239.80M
+11.2% YoY
|
262.34M
258.10M – 265.99M
+10.9% YoY
|
| EPS |
-2.69
est: -8.19 (+67.2%)
|
-1.87
est: -1.61 (-15.9%)
|
-1.46
est: -1.51 (+3.1%)
|
-1.22
est: -1.24 (+1.5%)
|
-1.38
est: -1.46 (+5.2%)
|
-1.05
est: -1.11 (+5.0%)
|
-1.38
est: -1.27 (-8.7%)
|
-0.59
est: -0.59 (+0.8%)
|
-0.46
-0.46 – -0.45
+23.4% YoY
|
-0.30
-0.31 – -0.30
+33.5% YoY
|
-0.18
-0.18 – -0.18
+40.5% YoY
|
-0.08
-0.08 – -0.08
+55.6% YoY
|
-0.05
-0.05 – -0.05
+37.5% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-01 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-30 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-3.49M
OE per share TTM
-0.05
Owner's Yield
-3.95%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
16.2%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
16
Total invested
1.33M
Insider transactions (90d)
2
Beneficial owners (>5%)
39
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MADRYN ASSET MANAGEMENT, LP | 24.24M | 43.60% | — | 24.24M | — | 24.24M | IA | — | 2024-12-17 | ↗ |
| 2 | MADRYN HEALTH ADVISORS GP II, LLC | 21.59M | 38.80% | — | 21.59M | — | 21.59M | PN | — | 2024-12-17 | ↗ |
| 3 | MADRYN HEALTH ADVISORS II, LP | 21.59M | 38.80% | — | 21.59M | — | 21.59M | PN | — | 2024-12-17 | ↗ |
| 4 | MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP | 20.26M | 36.40% | — | 20.26M | — | 20.26M | PN | — | 2024-12-17 | ↗ |
| 5 | Cannell Capital LLC | 2.83M | 9.80% | — | 2.83M | — | — | IA | Wyoming, USA | 2023-09-11 | ↗ |
| 6 | J. Carlo Cannell | 2.83M | 9.80% | — | 2.83M | — | — | IN | USA | 2023-09-11 | ↗ |
| 7 | MADRYN SELECT ADVISORS GP, LLC | 2.64M | 4.70% | — | 2.64M | — | 2.64M | PN | — | 2024-12-17 | ↗ |
| 8 | MADRYN SELECT ADVISORS, LP | 2.64M | 4.70% | — | 2.64M | — | 2.64M | PN | — | 2024-12-17 | ↗ |
| 9 | MADRYN SELECT OPPORTUNITIES, LP | 2.64M | 4.70% | — | 2.64M | — | 2.64M | PN | — | 2024-12-17 | ↗ |
| 10 | 94-3366999 | 2.63M | 9.98% | — | 2.63M | — | — | IA | Wyoming, USA | 2022-02-14 | ↗ |
| 11 | Schroder Investment Management North America Inc. | 1.84M | 6.99% | 1.84M | — | 1.84M | — | IA | — | 2022-02-09 | ↗ |
| 12 | Investor Growth Capital, LLC | 1.79M | 10.20% | 1.79M | — | 1.79M | — | HC | Sweden | 2019-02-14 | ↗ |
| 13 | Investor Growth Capital Holding, LLC | 1.79M | 9.60% | 1.79M | — | 1.79M | — | HC | Delaware | 2020-02-14 | ↗ |
| 14 | Divisadero Street Capital Management, LP | 1.54M | 5.20% | — | 1.54M | — | 1.54M | IA, PN | Delaware | 2024-04-01 | ↗ |
| 15 | Divisadero Street Partners GP, LLC | 1.54M | 5.20% | — | 1.54M | — | 1.54M | HC, OO | Delaware | 2024-04-01 | ↗ |
| 16 | Divisadero Street Partners, L.P. | 1.54M | 5.20% | — | 1.54M | — | 1.54M | PN | Delaware | 2024-04-01 | ↗ |
| 17 | William Zolezzi | 1.54M | 5.20% | — | 1.54M | — | 1.54M | HC, IN | Delaware | 2024-04-01 | ↗ |
| 18 | Benjamin Natter | 1.50M | 5.00% | — | 1.50M | — | — | HC, IN | United States | 2024-06-28 | ↗ |
| 19 | Kent Lake Capital LLC | 1.50M | 5.00% | — | 1.50M | — | — | IA, HC | Delaware | 2024-06-28 | ↗ |
| 20 | Kent Lake Partners LP | 1.50M | 5.00% | — | 1.50M | — | — | PN | Delaware | 2024-06-28 | ↗ |
| 21 | MADRYN HEALTH PARTNERS II, LP | 1.34M | 2.40% | — | 1.34M | — | 1.34M | PN | — | 2024-12-17 | ↗ |
| 22 | Granite Point Capital L.L.C. | 1.30M | 6.90% | — | 1.30M | — | — | CO | Delaware | 2020-09-18 | ↗ |
| 23 | Granite Point Capital Management, L.P. | 1.30M | 6.90% | — | 1.30M | — | — | IA, PN | Delaware | 2020-09-18 | ↗ |
| 24 | Warren B. Lammert, III | 1.30M | 6.90% | — | 1.30M | — | — | IN | United States | 2020-09-18 | ↗ |
| 25 | Deerfield Management Company, L.P. | 1.08M | 5.77% | — | 1.08M | — | — | PN | Delaware | 2019-12-19 | ↗ |
| 26 | Deerfield Mgmt, L.P. | 1.08M | 5.77% | — | 1.08M | — | — | PN | Delaware | 2019-12-19 | ↗ |
| 27 | James E. Flynn | 1.08M | 5.77% | — | 1.08M | — | — | IN | United States | 2019-12-19 | ↗ |
| 28 | Archon Capital Management LLC | 1.06M | 5.61% | — | 1.06M | — | 1.06M | IA, OO | United States | 2021-02-16 | ↗ |
| 29 | Constantinos Christofilis | 1.06M | 5.61% | — | 1.06M | — | 1.06M | HC, IN | United States | 2021-02-16 | ↗ |
| 30 | of 6 Pages | 746.8K | 4.25% | 746.8K | — | 746.8K | — | PN | Delaware | 2019-02-14 | ↗ |
| 31 | Deerfield Partners, L.P. | 735.5K | 3.95% | — | 735.5K | — | — | PN | Delaware | 2019-12-19 | ↗ |
| 32 | Granite Point Capital Master Fund, L.P. | 600.0K | 3.20% | — | 600.0K | — | — | PN | Cayman Islands | 2020-09-18 | ↗ |
| 33 | (1) BlackRock, Inc. | 420.6K | 1.60% | 420.4K | — | 420.6K | — | HC | Delaware | 2022-07-08 | ↗ |
| 34 | Granite Point Capital Panacea Global Healthcare Fund | 350.0K | 1.90% | — | 350.0K | — | — | PN | Delaware | 2020-09-18 | ↗ |
| 35 | Granite Point Capital Scorpion Focused Ideas Fund | 350.0K | 1.90% | — | 350.0K | — | — | PN | Delaware | 2020-09-18 | ↗ |
| 36 | Deerfield Special Situations Fund, L.P. | 339.5K | 1.82% | — | 339.5K | — | — | PN | Delaware | 2019-12-19 | ↗ |
| 37 | Gilbert H. Kliman (the Managing Director of InterWest Management Partners VIII, LLC) | 1.0K | 0.00% | 1.0K | — | 1.0K | — | IN | California | 2022-02-14 | ↗ |
| 38 | InterWest Management Partners VIII, LLC (the General Partner of InterWest Partners VIII, LP) | — | 0.00% | — | — | — | — | OO | California | 2022-02-14 | ↗ |
| 39 | InterWest Partners VIII, LP | — | 0.00% | — | — | — | — | PN | California | 2022-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
16
-86 vs prev Q
New positions
7
Closed positions
87
Increased
11
Reduced
2
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | MADRYN ASSET MANAGEMENT, LP | 18.48M +18.5M (+100.0%) | 25.50B +25.5B (+100.0%) | 27.45% +27.449 pp | 73.43% +73.427 pp | USD1.38 +0.0% | 1 qtrs NEW |
| 2 | UBS GROUP AG | 2.61M +442.2K (+20.4%) | 3.60M -2.3M (-39.1%) | 3.87% +0.602 pp | 0.00% 0.000 pp | USD2.51 -45.0% | 19 qtrs — |
| 3 | VANGUARD GROUP INC | 2.58M -249.7K (-8.8%) | 3.56M -4.2M (-53.9%) | 3.84% -0.443 pp | 0.00% 0.000 pp | USD7.90 -82.5% | 31 qtrs — |
| 4 | BALYASNY ASSET MANAGEMENT L.P. | 2.55M +730.8K (+40.1%) | 3.52M -1.5M (-29.2%) | 3.79% +1.040 pp | 0.00% -0.002 pp | USD2.17 -36.4% | 12 qtrs — |
| 5 | BLACKROCK, INC. | 2.35M +50.3K (+2.2%) | 3.25M -3.0M (-48.3%) | 3.50% +0.016 pp | 0.00% 0.000 pp | USD2.98 -53.7% | 6 qtrs — |
| 6 | LANE GENERATIONAL LLC | 1.71M +1.7M (+100.0%) | 2.35M +2.4M (+100.0%) | 2.53% +2.533 pp | 2.13% +2.132 pp | USD1.38 +0.0% | 1 qtrs NEW |
| 7 | JANE STREET GROUP, LLC | 1.02M +783.2K (+333.8%) | 1.40M +764.1K (+119.3%) | 1.51% +1.158 pp | 0.00% +0.000 pp | USD1.69 -18.3% | 4 qtrs — |
| 8 | MASTERS CAPITAL MANAGEMENT LLC | 1.00M +— (+0.0%) | 1.38M -1.4M (-49.5%) | 1.49% -0.025 pp | 0.06% -0.043 pp | USD0.93 +48.4% | 6 qtrs — |
| 9 | FOURWORLD CAPITAL MANAGEMENT LLC | 931.3K +363.3K (+64.0%) | 1.29M -265.5K (-17.1%) | 1.38% +0.525 pp | 1.04% -1.406 pp | USD1.39 -0.7% | 8 qtrs — |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 891.7K +14.8K (+1.7%) | 1.23M -1.2M (-48.6%) | 1.32% 0.000 pp | 0.00% 0.000 pp | USD5.69 -75.7% | 30 qtrs — |
| 11 | IKARIAN CAPITAL, LLC | 701.2K -204.5K (-22.6%) | 967.6K -1.5M (-60.9%) | 1.04% -0.327 pp | 0.08% -0.174 pp | USD3.68 -62.5% | 4 qtrs — |
| 12 | WEXFORD CAPITAL LP | 645.0K -532.3K (-45.2%) | 890.0K -2.3M (-72.3%) | 0.96% -0.821 pp | 0.17% -0.290 pp | USD3.22 -57.1% | 4 qtrs — |
| 13 | STATE STREET CORP | 584.2K -3.5K (-0.6%) | 806.2K -798.1K (-49.7%) | 0.87% -0.020 pp | 0.00% +0.000 pp | USD5.03 -72.6% | 19 qtrs — |
| 14 | HIGHTOWER ADVISORS, LLC | 564.3K -12.8K (-2.2%) | 778.7K -796.7K (-50.6%) | 0.84% -0.034 pp | 0.00% -0.001 pp | USD2.80 -50.7% | 22 qtrs — |
| 15 | RENAISSANCE TECHNOLOGIES LLC | 474.9K +474.9K (+100.0%) | 655.4K +655.4K (+100.0%) | 0.71% +0.706 pp | 0.00% +0.001 pp | USD1.38 +0.0% | 1 qtrs NEW |
| 16 | GOLDMAN SACHS GROUP INC | 332.0K +110.0K (+49.6%) | 458.1K -147.7K (-24.4%) | 0.49% +0.158 pp | 0.00% +0.000 pp | USD2.87 -51.9% | 5 qtrs — |
| 17 | XTX TOPCO LTD | 314.2K +285.4K (+992.6%) | 433.6K +355.1K (+452.3%) | 0.47% +0.423 pp | 0.01% +0.007 pp | USD1.50 -8.0% | 2 qtrs — |
| 18 | MARSHALL WACE, LLP | 286.0K -639.1K (-69.1%) | 394.7K -2.1M (-84.4%) | 0.43% -0.973 pp | 0.00% -0.002 pp | USD2.77 -50.2% | 4 qtrs — |
| 19 | NORTHERN TRUST CORP | 278.4K +1.8K (+0.6%) | 384.2K -371.0K (-49.1%) | 0.41% -0.004 pp | 0.00% +0.000 pp | USD5.28 -73.9% | 31 qtrs — |
| 20 | ADVISORSHARES INVESTMENTS LLC | 270.9K +80.8K (+42.5%) | 373.9K -145.2K (-28.0%) | 0.40% +0.115 pp | 0.06% -0.022 pp | USD2.69 -48.7% | 5 qtrs — |
| 21 | JBF CAPITAL, INC. | 233.2K +233.2K (+100.0%) | 321.8K +321.8K (+100.0%) | 0.35% +0.346 pp | 0.05% +0.046 pp | USD1.38 +0.0% | 1 qtrs NEW |
| 22 | MASSAR CAPITAL MANAGEMENT, LP | 221.0K -19.0K (-7.9%) | 305.0K -350.2K (-53.5%) | 0.33% -0.034 pp | 0.03% -0.054 pp | USD3.60 -61.7% | 4 qtrs — |
| 23 | PEAK6 LLC | 200.0K +— (+0.0%) | 276.0K -270.0K (-49.5%) | 0.30% -0.005 pp | 0.00% 0.000 pp | USD2.73 -49.5% | 2 qtrs — |
| 24 | TWO SIGMA INVESTMENTS, LP | 198.7K -136.0K (-40.6%) | 274.3K -639.6K (-70.0%) | 0.30% -0.211 pp | 0.00% -0.001 pp | USD3.68 -62.5% | 4 qtrs — |
| 25 | FREEGULLIVER LLC | 190.0K +190.0K (+100.0%) | 262.2K +262.2K (+100.0%) | 0.28% +0.282 pp | 0.10% +0.097 pp | USD1.38 +0.0% | 1 qtrs NEW |
| 26 | BOOTHBAY FUND MANAGEMENT, LLC | 175.0K -102.9K (-37.0%) | 241.5K -517.2K (-68.2%) | 0.26% -0.160 pp | 0.00% -0.007 pp | USD3.68 -62.5% | 4 qtrs — |
| 27 | TWO SIGMA ADVISERS, LP | 169.0K +64.8K (+62.2%) | 233.2K -51.2K (-18.0%) | 0.25% +0.094 pp | 0.00% 0.000 pp | USD2.80 -50.7% | 4 qtrs — |
| 28 | DAUNTLESS INVESTMENT GROUP, LLC | 160.9K +160.9K (+100.0%) | 222.1K +222.1K (+100.0%) | 0.24% +0.239 pp | 0.18% +0.176 pp | USD1.38 +0.0% | 1 qtrs NEW |
| 29 | ARISTIDES CAPITAL LLC | 136.4K +136.4K (+100.0%) | 188.2K +188.2K (+100.0%) | 0.20% +0.203 pp | 0.03% +0.033 pp | USD1.38 +0.0% | 1 qtrs NEW |
| 30 | MORGAN STANLEY | 116.4K -359.3K (-75.5%) | 160.7K -1.1M (-87.6%) | 0.17% -0.546 pp | 0.00% 0.000 pp | USD3.51 -60.7% | 30 qtrs — |
| 31 | QUBE RESEARCH & TECHNOLOGIES LTD | 108.2K +108.2K (+100.0%) | 149.3K +149.3K (+100.0%) | 0.16% +0.161 pp | 0.00% +0.000 pp | USD1.38 +0.0% | 4 qtrs — |
| 32 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 95.2K +25.0K (+35.6%) | 131.4K -60.3K (-31.5%) | 0.14% +0.035 pp | 0.00% -0.001 pp | USD2.97 -53.5% | 26 qtrs — |
| 33 | CAPTION MANAGEMENT, LLC | 92.5K +78.7K (+571.4%) | 127.7K +90.0K (+239.4%) | 0.14% +0.117 pp | 0.00% +0.001 pp | USD1.58 -12.7% | 2 qtrs — |
| 34 | BANK OF AMERICA CORP /DE/ | 92.4K -22.2K (-19.4%) | 127.5K -185.5K (-59.3%) | 0.14% -0.036 pp | 0.00% +0.000 pp | USD3.68 -62.5% | 31 qtrs — |
| 35 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 91.1K -15.0K (-14.1%) | 125.8K -164.0K (-56.6%) | 0.14% -0.025 pp | 0.00% +0.000 pp | USD3.52 -60.8% | 4 qtrs — |
| 36 | CITADEL ADVISORS LLC | 79.5K +26.4K (+49.7%) | 109.7K -35.3K (-24.3%) | 0.12% +0.038 pp | 0.00% +0.000 pp | USD2.47 -44.1% | 13 qtrs — |
| 37 | GAMCO INVESTORS, INC. ET AL | 79.2K +— (+0.0%) | 109.3K -106.9K (-49.5%) | 0.12% -0.002 pp | 0.00% -0.001 pp | USD5.00 -72.4% | 20 qtrs — |
| 38 | BANK OF NEW YORK MELLON CORP | 78.6K -2.7K (-3.3%) | 108.5K -113.5K (-51.1%) | 0.12% -0.006 pp | 0.00% +0.000 pp | USD3.48 -60.3% | 3 qtrs — |
| 39 | FMR LLC | 78.2K +31.2K (+66.3%) | 108.0K -20.4K (-15.9%) | 0.12% +0.045 pp | 0.00% +0.000 pp | USD7.53 -81.7% | 31 qtrs — |
| 40 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 72.4K +— (+0.0%) | 99.9K -97.7K (-49.5%) | 0.11% -0.002 pp | 0.00% -0.001 pp | USD2.73 -49.5% | 4 qtrs — |
| 41 | CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 69.8K +67.2K (+2,667.0%) | 96.3K +89.4K (+1,298.8%) | 0.10% +0.100 pp | 0.02% +0.019 pp | USD1.46 -5.5% | 4 qtrs — |
| 42 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 63.7K -9.6K (-13.1%) | 87.9K -112.2K (-56.1%) | 0.09% -0.016 pp | 0.00% +0.000 pp | USD3.01 -54.2% | 4 qtrs — |
| 43 | BARCLAYS PLC | 61.6K +9.9K (+19.2%) | 85.0K -56.0K (-39.7%) | 0.09% +0.014 pp | 0.00% +0.000 pp | USD3.15 -56.2% | 3 qtrs — |
| 44 | INVESCO LTD. | 58.9K +26.2K (+80.0%) | 81.3K -8.1K (-9.0%) | 0.09% +0.038 pp | 0.00% +0.000 pp | USD2.50 -44.8% | 3 qtrs — |
| 45 | CRUISER CAPITAL ADVISORS, LLC | 48.9K -1.1K (-2.2%) | 67.5K -69.0K (-50.6%) | 0.07% -0.003 pp | 0.06% -0.079 pp | USD3.68 -62.5% | 4 qtrs — |
| 46 | RHUMBLINE ADVISERS | 48.4K -7.2K (-12.9%) | 66.8K -85.0K (-56.0%) | 0.07% -0.012 pp | 0.00% 0.000 pp | USD3.45 -60.0% | 3 qtrs — |
| 47 | GROUP ONE TRADING, L.P. | 48.3K -47.5K (-49.6%) | 66.7K -194.9K (-74.5%) | 0.07% -0.073 pp | 0.00% 0.000 pp | USD2.87 -51.9% | 4 qtrs — |
| 48 | ROYAL BANK OF CANADA | 47.2K +7.1K (+17.7%) | 65.0K -45.0K (-40.9%) | 0.07% +0.010 pp | 0.00% +0.000 pp | USD2.53 -45.5% | 3 qtrs — |
| 49 | NUVEEN, LLC | 47.0K +— (+0.0%) | 64.9K -63.5K (-49.5%) | 0.07% -0.001 pp | 0.00% +0.000 pp | USD3.49 -60.5% | 3 qtrs — |
| 50 | DEUTSCHE BANK AG\ | 45.8K +1.9K (+4.4%) | 63.2K -56.5K (-47.2%) | 0.07% +0.002 pp | 0.00% +0.000 pp | USD2.69 -48.7% | 3 qtrs — |
| 51 | WELLS FARGO & COMPANY/MN | 43.3K +19.2K (+79.5%) | 59.7K -6.1K (-9.2%) | 0.06% +0.028 pp | 0.00% +0.000 pp | USD2.58 -46.5% | 4 qtrs — |
| 52 | SIMPLEX TRADING, LLC | 43.1K -101.4K (-70.2%) | 59.5K -334.5K (-84.9%) | 0.06% -0.154 pp | 0.00% 0.000 pp | USD2.97 -53.5% | 4 qtrs — |
| 53 | BLUECREST CAPITAL MANAGEMENT LTD | 40.0K +40.0K (+100.0%) | 55.2K +55.2K (+100.0%) | 0.06% +0.059 pp | 0.00% +0.002 pp | USD1.38 +0.0% | 1 qtrs NEW |
| 54 | GABELLI FUNDS LLC | 38.0K +— (+0.0%) | 52.4K -51.3K (-49.5%) | 0.06% -0.001 pp | 0.00% 0.000 pp | USD4.81 -71.3% | 25 qtrs — |
| 55 | PRESIDIO CAPITAL MANAGEMENT, LLC | 37.4K +25.6K (+217.0%) | 51.7K +19.4K (+60.2%) | 0.06% +0.038 pp | 0.02% +0.004 pp | USD1.81 -23.8% | 4 qtrs — |
| 56 | PRICE T ROWE ASSOCIATES INC /MD/ | 36.9K +— (+0.0%) | 51.0K -50.0K (-49.5%) | 0.05% -0.001 pp | 0.00% +0.000 pp | USD3.28 -57.9% | 20 qtrs — |
| 57 | TRADEWINDS, LLC. | 36.4K -102.0K (-73.7%) | 50.3K -327.8K (-86.7%) | 0.05% -0.155 pp | 0.01% -0.080 pp | USD2.73 -49.5% | 5 qtrs — |
| 58 | PATHSTONE HOLDINGS, LLC | 32.2K +32.2K (+100.0%) | 44.5K +44.5K (+100.0%) | 0.05% +0.048 pp | 0.00% +0.000 pp | USD1.38 +0.0% | 1 qtrs NEW |
| 59 | NATIONAL BANK OF CANADA /FI/ | 32.0K +120.0 (+0.4%) | 43.8K -43.2K (-49.6%) | 0.05% -0.001 pp | 0.00% +0.000 pp | USD3.38 -59.2% | 5 qtrs — |
| 60 | DAVID J YVARS GROUP | 31.2K +5.7K (+22.1%) | 43.1K -26.7K (-38.3%) | 0.05% +0.008 pp | 0.02% -0.015 pp | USD2.37 -41.8% | 21 qtrs — |
| 61 | ALLIANCEBERNSTEIN L.P. | 28.8K +— (+0.0%) | 39.7K -38.9K (-49.5%) | 0.04% -0.001 pp | 0.00% +0.000 pp | USD3.21 -57.0% | 3 qtrs — |
| 62 | ABEL HALL, LLC | 28.6K +28.6K (+100.0%) | 39.5K +39.5K (+100.0%) | 0.04% +0.043 pp | 0.01% +0.009 pp | USD1.38 +0.0% | 1 qtrs NEW |
| 63 | SQUAREPOINT OPS LLC | 23.2K -39.3K (-62.8%) | 32.0K -138.5K (-81.2%) | 0.03% -0.060 pp | 0.00% 0.000 pp | USD3.52 -60.8% | 4 qtrs — |
| 64 | FIELDER CAPITAL GROUP LLC | 22.8K +— (+0.0%) | 31.5K -30.8K (-49.5%) | 0.03% -0.001 pp | 0.01% -0.008 pp | USD2.90 -52.4% | 9 qtrs — |
| 65 | FERMATA ADVISORS, LLC | 19.8K +5.5K (+38.3%) | 27.4K -11.8K (-30.1%) | 0.03% +0.008 pp | 0.01% -0.003 pp | USD2.91 -52.6% | 3 qtrs — |
| 66 | VERITION FUND MANAGEMENT LLC | 18.0K +— (+0.0%) | 24.9K -24.4K (-49.5%) | 0.03% -0.001 pp | 0.00% 0.000 pp | USD3.68 -62.5% | 4 qtrs — |
| 67 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 17.2K +460.0 (+2.8%) | 23.7K -21.9K (-48.1%) | 0.03% +0.000 pp | 0.00% +0.000 pp | USD3.43 -59.8% | 3 qtrs — |
| 68 | INTECH INVESTMENT MANAGEMENT LLC | 17.0K -1.0K (-5.8%) | 23.5K -25.8K (-52.4%) | 0.03% -0.002 pp | 0.00% 0.000 pp | USD3.49 -60.5% | 3 qtrs — |
| 69 | STONEX GROUP INC. | 16.9K +16.9K (+100.0%) | 23.3K +23.3K (+100.0%) | 0.03% +0.025 pp | 0.00% +0.001 pp | USD1.38 +0.0% | 1 qtrs NEW |
| 70 | JPMORGAN CHASE & CO | 16.6K +1.9K (+12.7%) | 22.9K -17.3K (-43.0%) | 0.02% +0.002 pp | 0.00% +0.000 pp | USD3.25 -57.5% | 19 qtrs — |
| 71 | MILLENNIUM MANAGEMENT LLC | 10.8K -372.9K (-97.2%) | 14.9K -1.0M (-98.6%) | 0.02% -0.564 pp | 0.00% 0.000 pp | USD3.63 -62.0% | 4 qtrs — |
| 72 | ENGINEERS GATE MANAGER LP | 10.7K +10.7K (+100.0%) | 14.7K +14.7K (+100.0%) | 0.02% +0.016 pp | 0.00% +0.000 pp | USD1.38 +0.0% | 6 qtrs — |
| 73 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 9.7K +— (+0.0%) | 13.4K -13.1K (-49.5%) | 0.01% 0.000 pp | 0.00% 0.000 pp | USD3.49 -60.5% | 3 qtrs — |
| 74 | BNP PARIBAS ARBITRAGE, SNC | 8.6K +1.3K (+18.1%) | 11.9K -8.0K (-40.3%) | 0.01% +0.002 pp | 0.00% +0.000 pp | USD2.80 -50.7% | 3 qtrs — |
| 75 | TOWER RESEARCH CAPITAL LLC (TRC) | 8.1K +3.3K (+68.5%) | 11.1K -1.9K (-14.8%) | 0.01% +0.005 pp | 0.00% 0.000 pp | USD2.64 -47.7% | 20 qtrs — |
| 76 | NEW YORK STATE COMMON RETIREMENT FUND | 5.8K +— (+0.0%) | 8.0K -7.8K (-49.5%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD3.49 -60.5% | 3 qtrs — |
| 77 | LEGAL & GENERAL GROUP PLC | 4.0K +— (+0.0%) | 5.6K -5.4K (-49.4%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD3.49 -60.5% | 3 qtrs — |
| 78 | AMERITAS INVESTMENT PARTNERS, INC. | 3.7K +— (+0.0%) | 5.1K -5.0K (-49.4%) | 0.01% 0.000 pp | 0.00% 0.000 pp | USD3.49 -60.5% | 3 qtrs — |
| 79 | MCF ADVISORS LLC | 3.6K +— (+0.0%) | 4.9K -4.8K (-49.4%) | 0.01% 0.000 pp | 0.00% 0.000 pp | USD4.12 -66.5% | 20 qtrs — |
| 80 | RUSSELL INVESTMENTS GROUP, LTD. | 3.2K +212.0 (+7.1%) | 4.4K -3.8K (-45.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.64 -47.7% | 2 qtrs — |
| 81 | ADDISON ADVISORS LLC | 3.0K +— (+0.0%) | 4.1K -4.1K (-49.5%) | 0.00% 0.000 pp | 0.00% -0.001 pp | USD6.56 -79.0% | 18 qtrs — |
| 82 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 2.4K +164.0 (+7.3%) | 3.3K -2.8K (-45.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.35 -58.8% | 3 qtrs — |
| 83 | WOODBRIDGE CO LTD | 1.8K +— (+0.0%) | 2.5K -2.5K (-49.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.49 -60.5% | 3 qtrs — |
| 84 | ROCKEFELLER CAPITAL MANAGEMENT L.P. | 1.5K +— (+0.0%) | 2.1K -2.0K (-49.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.73 -49.5% | 2 qtrs — |
| 85 | AMALGAMATED BANK | 1.2K +4.0 (+0.3%) | 2.0K -1.0K (-33.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.48 -60.3% | 3 qtrs — |
| 86 | CITIGROUP INC | 1.1K -12.1K (-91.5%) | 1.6K -34.6K (-95.7%) | 0.00% -0.018 pp | 0.00% +0.000 pp | USD3.49 -60.5% | 21 qtrs — |
| 87 | ADVISOR GROUP HOLDINGS, INC. | 795.00 -9.0 (-1.1%) | 1.1K -1.4K (-56.1%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.47 -44.1% | 24 qtrs — |
| 88 | GAMMA INVESTING LLC | 681.00 +681.0 (+100.0%) | 940.00 +940.0 (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD1.38 +0.0% | 1 qtrs NEW |
| 89 | SBI SECURITIES CO., LTD. | 453.00 -2.0 (-0.4%) | 625.00 -617.0 (-49.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.61 -14.3% | 5 qtrs — |
| 90 | MAI CAPITAL MANAGEMENT | 300.00 +— (+0.0%) | 414.00 -405.0 (-49.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.61 -14.3% | 5 qtrs — |
| 91 | FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 254.00 +— (+0.0%) | 350.00 -343.0 (-49.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.01 -54.2% | 5 qtrs — |
| 92 | STERLING CAPITAL MANAGEMENT LLC | 235.00 +147.0 (+167.0%) | 324.00 +84.0 (+35.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.16 -36.1% | 3 qtrs — |
| 93 | — | 100.00 +100.0 (+100.0%) | 138.00 +138.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.38 +0.0% | 1 qtrs NEW |
| 94 | CIBC PRIVATE WEALTH GROUP, LLC | 20.00 +— (+0.0%) | 28.00 -27.0 (-49.1%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.60 -13.8% | 5 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 16 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Invesco NASDAQ Future Gen 200 ETF QQQS | 0.57% | 125.4K | 0.20% |
| 2 | iShares Micro-Cap ETF IWC | 0.01% | 164.5K | 0.60% |
| 3 | Vanguard Russell 2000 Growth ETF VTWG | 0.00% | 54.0K | 0.06% |
| 4 | Vanguard Russell 2000 ETF VTWO | 0.00% | 285.3K | 0.06% |
| 5 | Vanguard Extended Market ETF VXF | 0.00% | 638.7K | 0.05% |
| 6 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 14.3K | 0.17% |
| 7 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 1.1K | 0.17% |
| 8 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 5.2K | 0.03% |
| 9 | Vanguard Total Stock Market ETF VTI | 0.00% | 2.44M | 0.03% |
| 10 | Vanguard Russell 3000 ETF VTHR | 0.00% | 4.5K | 0.06% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
2
Sells
0
Shares acquired
200.0K
Shares disposed
—
Cash buys
2.00
Cash sales
—
Net activity
+200,000
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-21 | Chernett Jorey | 10% Owner | P-Purchase | A | Common Stock | 100,000 | 1.51 | 151.0K | 9,978,988 | D | ↗ |
| 2026-04-20 | Chernett Jorey | 10% Owner | P-Purchase | A | Common Stock | 100,000 | 1.58 | 158.0K | 9,878,988 | D | ↗ |
| 2026-03-30 | Chernett Jorey | 10% Owner | P-Purchase | A | Common Stock | 385,442 | 1.25 | 481.8K | 9,778,988 | D | ↗ |
| 2026-03-27 | Chernett Jorey | 10% Owner | P-Purchase | A | Common Stock | 500,000 | 1.35 | 675.0K | 9,393,276 | D | ↗ |
| 2026-03-26 | Chernett Jorey | 10% Owner | P-Purchase | A | Common Stock | 25,000 | 1.44 | 36.0K | 8,893,276 | D | ↗ |
| 2026-03-25 | Chernett Jorey | 10% Owner | P-Purchase | A | Common Stock | 125,000 | 1.40 | 175.0K | 8,868,276 | D | ↗ |
| 2026-03-23 | REUVERS DANIEL L. | Officer | A-Award | A | Common Stock | 1,500,000 | 0.00 | — | 1,500,000 | D | ↗ |
| 2026-03-20 | Chernett Jorey | 10% Owner | P-Purchase | A | Common Stock | 169,472 | 1.41 | 239.0K | 8,743,276 | D | ↗ |
| 2026-03-19 | Sullivan Keith J | Director / Officer | S-Sale | D | Common Stock | 46,289 | 1.34 | 62.0K | 1,590,924 | D | ↗ |
| 2026-03-19 | Pfanstiel Steven | Officer | S-Sale | D | Common Stock | 16,431 | 1.34 | 22.0K | 828,781 | D | ↗ |
| 2026-03-19 | MACAN WILLIAM ANDREW | Officer | S-Sale | D | Common Stock | 16,005 | 1.34 | 21.4K | 897,270 | D | ↗ |
| 2026-03-19 | Chernett Jorey | 10% Owner | P-Purchase | A | Common Stock | 450,000 | 1.33 | 598.5K | 8,573,804 | D | ↗ |
| 2026-03-18 | Chernett Jorey | 10% Owner | P-Purchase | A | Common Stock | 607,400 | 1.35 | 820.0K | 8,123,804 | D | ↗ |
| 2026-03-17 | Sullivan Keith J | Director / Officer | A-Award | A | Common Stock | 112,500 | 0.00 | — | 1,637,213 | D | ↗ |
| 2026-03-17 | Pfanstiel Steven | Officer | A-Award | A | Common Stock | 25,000 | 0.00 | — | 845,212 | D | ↗ |
| 2026-03-17 | MACAN WILLIAM ANDREW | Officer | A-Award | A | Common Stock | 33,750 | 0.00 | — | 913,275 | D | ↗ |
| 2026-03-17 | Chernett Jorey | 10% Owner | P-Purchase | A | Common Stock | 531,000 | 1.16 | 616.0K | 7,516,404 | D | ↗ |
| 2026-03-04 | MACAN WILLIAM ANDREW | Officer | S-Sale | D | Common Stock | 609 | 1.34 | 816.06 | 879,525 | D | ↗ |
| 2026-02-26 | Sullivan Keith J | Director / Officer | S-Sale | D | Common Stock | 8,452 | 1.35 | 11.4K | 1,524,713 | D | ↗ |
| 2026-02-26 | MACAN WILLIAM ANDREW | Officer | S-Sale | D | Common Stock | 3,427 | 1.35 | 4.6K | 880,134 | D | ↗ |
| 2026-02-23 | Pfanstiel Steven | Officer | A-Award | A | Common Stock | 250,000 | 0.00 | — | 820,212 | D | ↗ |
| 2026-02-23 | MACAN WILLIAM ANDREW | Officer | A-Award | A | Common Stock | 210,000 | 0.00 | — | 883,561 | D | ↗ |
| 2026-02-12 | Sullivan Keith J | Director / Officer | S-Sale | D | Common Stock | 33,847 | 1.65 | 55.8K | 1,533,165 | D | ↗ |
| 2026-02-12 | MACAN WILLIAM ANDREW | Officer | S-Sale | D | Common Stock | 14,120 | 1.65 | 23.3K | 673,561 | D | ↗ |
| 2026-02-10 | Sullivan Keith J | Director / Officer | S-Sale | D | Common Stock | 40,976 | 1.55 | 63.5K | 1,567,012 | D | ↗ |
| 2026-02-10 | MACAN WILLIAM ANDREW | Officer | S-Sale | D | Common Stock | 3,485 | 1.55 | 5.4K | 687,681 | D | ↗ |
| 2025-12-30 | Pfanstiel Steven | Officer | A-Award | A | Common Stock | 170,212 | 0.00 | — | 570,212 | D | ↗ |
| 2025-12-30 | MACAN WILLIAM ANDREW | Officer | A-Award | A | Common Stock | 164,361 | 0.00 | — | 691,166 | D | ↗ |
| 2025-10-20 | MUIR GLENN P | Director | A-Award | A | Common Stock | 7,554 | 0.00 | — | 371,816 | D | ↗ |
| 2025-10-20 | Cucuz Sasha | Director | A-Award | A | Common Stock | 6,410 | 0.00 | — | 1,512,798 | D | ↗ |
| 2025-10-20 | CONLEY SHERYL L | Director | A-Award | A | Common Stock | 7,326 | 0.00 | — | 221,716 | D | ↗ |
| 2025-10-20 | CASCELLA ROBERT | Director | A-Award | A | Common Stock | 10,531 | 0.00 | — | 588,767 | D | ↗ |
| 2025-08-08 | Madryn Asset Management, LP | 10% Owner | S-Sale | D | Common Stock | 2,925,554 | 3.72 | 10.88M | 17,333,542 | I | ↗ |
| 2025-07-15 | Pfanstiel Steven | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-07-10 | Madryn Asset Management, LP | 10% Owner | G-Gift | A | Common Stock | 337,312 | 0.00 | — | 1,430,953 | I | ↗ |
| 2025-05-22 | Rosengarten Megan | Director | A-Award | A | Common Stock | 30,000 | 0.00 | — | 140,890 | D | ↗ |
| 2025-05-22 | MUIR GLENN P | Director | A-Award | A | Common Stock | 30,000 | 0.00 | — | 364,262 | D | ↗ |
| 2025-05-22 | Cucuz Sasha | Director | A-Award | A | Common Stock | 30,000 | 0.00 | — | 1,506,388 | D | ↗ |
| 2025-05-22 | CONLEY SHERYL L | Director | A-Award | A | Common Stock | 30,000 | 0.00 | — | 214,390 | D | ↗ |
| 2025-05-22 | CASCELLA ROBERT | Director | A-Award | A | Common Stock | 36,250 | 0.00 | — | 578,236 | D | ↗ |
| 2025-05-22 | Amin Avinash | Director | A-Award | A | Common Stock | 30,000 | 0.00 | — | 42,500 | D | ↗ |
| 2025-05-13 | Furlong Stephen | Officer | S-Sale | D | Common Stock | 6,540 | 4.16 | 27.2K | 410,053 | D | ↗ |
| 2025-05-12 | Furlong Stephen | Officer | S-Sale | D | Common Stock | 193,460 | 4.27 | 826.1K | 416,593 | D | ↗ |
| 2025-03-04 | MACAN WILLIAM ANDREW | Officer | S-Sale | D | Common Stock | 377 | 4.48 | 1.7K | 526,805 | D | ↗ |
| 2025-03-04 | Furlong Stephen | Officer | S-Sale | D | Common Stock | 1,867 | 4.48 | 8.4K | 610,053 | D | ↗ |
| 2025-02-24 | Sullivan Keith J | Director / Officer | A-Award | A | Common Stock | 375,000 | 0.00 | — | 1,607,988 | D | ↗ |
| 2025-02-24 | MACAN WILLIAM ANDREW | Officer | A-Award | A | Common Stock | 157,500 | 0.00 | — | 527,182 | D | ↗ |
| 2025-02-24 | Furlong Stephen | Officer | A-Award | A | Common Stock | 157,500 | 0.00 | — | 611,920 | D | ↗ |
| 2025-02-19 | Sullivan Keith J | Director / Officer | S-Sale | D | Common Stock | 24,440 | 4.70 | 114.9K | 1,232,988 | D | ↗ |
| 2025-02-18 | Sullivan Keith J | Director / Officer | S-Sale | D | Common Stock | 25,934 | 4.41 | 114.4K | 1,257,428 | D | ↗ |
| 2025-02-14 | MACAN WILLIAM ANDREW | Officer | S-Sale | D | Common Stock | 18,965 | 4.11 | 77.9K | 369,682 | D | ↗ |
| 2025-02-14 | Furlong Stephen | Officer | S-Sale | D | Common Stock | 17,307 | 4.11 | 71.1K | 454,420 | D | ↗ |
| 2025-02-12 | MACAN WILLIAM ANDREW | Officer | S-Sale | D | Common Stock | 12,175 | 3.83 | 46.6K | 388,647 | D | ↗ |
| 2025-02-12 | Furlong Stephen | Officer | S-Sale | D | Common Stock | 10,845 | 3.83 | 41.5K | 471,727 | D | ↗ |
| 2025-02-10 | Sullivan Keith J | Director / Officer | S-Sale | D | Common Stock | 40,992 | 3.28 | 134.5K | 1,283,362 | D | ↗ |
| 2025-02-10 | MACAN WILLIAM ANDREW | Officer | S-Sale | D | Common Stock | 1,970 | 3.28 | 6.5K | 400,822 | D | ↗ |
| 2025-02-10 | Furlong Stephen | Officer | S-Sale | D | Common Stock | 14,836 | 3.28 | 48.7K | 482,572 | D | ↗ |
| 2025-02-07 | MUIR GLENN P | Director | J-Other | A | Common Stock | 44,444 | 2.25 | 100.0K | 334,262 | D | ↗ |
| 2025-02-07 | Cucuz Sasha | Director | J-Other | A | Common Stock | 88,888 | 2.25 | 200.0K | 1,476,388 | D | ↗ |
| 2025-02-07 | CONLEY SHERYL L | Director | J-Other | A | Common Stock | 44,444 | 2.25 | 100.0K | 184,390 | D | ↗ |
| 2025-02-07 | CASCELLA ROBERT | Director | J-Other | A | Common Stock | 88,888 | 2.25 | 200.0K | 541,986 | D | ↗ |
| 2024-12-10 | Sullivan Keith J | Director / Officer | A-Award | A | Performance Restricted Stock Unit | 450,000 | 0.00 | — | 450,000 | D | ↗ |
| 2024-12-10 | Madryn Asset Management, LP | 10% Owner | — | — | Common Stock | 0 | 0.00 | — | 24,237,061 | I | ↗ |
| 2024-12-10 | MACAN WILLIAM ANDREW | Officer | A-Award | A | Performance Restricted Stock Unit | 135,000 | 0.00 | — | 135,000 | D | ↗ |
| 2024-12-10 | Furlong Stephen | Officer | A-Award | A | Performance Restricted Stock Unit | 150,000 | 0.00 | — | 150,000 | D | ↗ |
| 2024-12-10 | Cucuz Sasha | Director | — | — | Common Stock | 0 | 0.00 | — | 2,042 | I | ↗ |
| 2024-12-10 | Amin Avinash | Director | — | — | Common Stock | 0 | 0.00 | — | 12,500 | D | ↗ |
| 2024-10-08 | MACAN WILLIAM ANDREW | Officer | S-Sale | D | Common Stock | 1,541 | 0.82 | 1.3K | 402,792 | D | ↗ |
| 2024-10-08 | Furlong Stephen | Officer | S-Sale | D | Common Stock | 1,368 | 0.82 | 1.1K | 497,408 | D | ↗ |
| 2024-09-12 | CASCELLA ROBERT | Director | P-Purchase | A | Common Stock | 100,000 | 0.75 | 75.0K | 453,098 | — | ↗ |
| 2024-09-05 | MUIR GLENN P | Director | P-Purchase | A | Common Stock | 25,000 | 0.80 | 20.0K | 289,818 | — | ↗ |
| 2024-08-29 | MUIR GLENN P | Director | P-Purchase | A | Common Stock | 12,224 | 0.85 | 10.4K | 264,818 | — | ↗ |
| 2024-08-28 | MUIR GLENN P | Director | P-Purchase | A | Common Stock | 12,776 | 0.85 | 10.9K | 252,594 | — | ↗ |
| 2024-08-20 | MUIR GLENN P | Director | P-Purchase | A | Common Stock | 25,000 | 1.00 | 25.0K | 239,818 | — | ↗ |
| 2024-08-19 | CASCELLA ROBERT | Director | P-Purchase | A | Common Stock | 4,000 | 1.14 | 4.6K | 353,098 | — | ↗ |
| 2024-08-16 | CASCELLA ROBERT | Director | P-Purchase | A | Common Stock | 35,000 | 1.06 | 37.1K | 349,098 | — | ↗ |
| 2024-08-15 | CASCELLA ROBERT | Director | P-Purchase | A | Common Stock | 35,000 | 0.88 | 30.8K | 314,098 | — | ↗ |
| 2024-08-14 | MUIR GLENN P | Director | P-Purchase | A | Common Stock | 25,171 | 0.75 | 18.9K | 214,818 | — | ↗ |
| 2024-08-14 | CASCELLA ROBERT | Director | P-Purchase | A | Common Stock | 35,000 | 0.79 | 27.7K | 279,098 | — | ↗ |
| 2024-07-18 | Sullivan Keith J | Director / Officer | S-Sale | D | Common Stock | 24,162 | 1.90 | 45.9K | 1,324,354 | — | ↗ |
| 2024-07-17 | Sullivan Keith J | Director / Officer | S-Sale | D | Common Stock | 11,687 | 1.97 | 23.0K | 1,348,516 | — | ↗ |
| 2024-07-16 | Sullivan Keith J | Director / Officer | S-Sale | D | Common Stock | 12,075 | 1.91 | 23.1K | 1,360,203 | — | ↗ |
| 2024-06-06 | CASCELLA ROBERT | Director | P-Purchase | A | Common Stock | 50,000 | 2.05 | 102.6K | 244,098 | — | ↗ |
| 2024-05-30 | Rosengarten Megan | Director | A-Award | A | Common Stock | 25,000 | 0.00 | — | 110,890 | — | ↗ |
| 2024-05-30 | MUIR GLENN P | Director | A-Award | A | Common Stock | 25,000 | 0.00 | — | 189,647 | — | ↗ |
| 2024-05-30 | CONLEY SHERYL L | Director | A-Award | A | Common Stock | 25,000 | 0.00 | — | 139,946 | — | ↗ |
| 2024-05-30 | CASCELLA ROBERT | Director | A-Award | A | Common Stock | 31,250 | 0.00 | — | 194,098 | — | ↗ |
| 2024-02-29 | MACAN WILLIAM ANDREW | Officer | A-Award | A | Common Stock | 15,000 | 0.00 | — | 404,333 | — | ↗ |
| 2024-02-29 | Furlong Stephen | Officer | A-Award | A | Common Stock | 15,000 | 0.00 | — | 498,776 | — | ↗ |
| 2024-02-28 | MACAN WILLIAM ANDREW | Officer | S-Sale | D | Common Stock | 22,377 | 3.16 | 70.7K | 395,359 | — | ↗ |
| 2024-02-28 | Furlong Stephen | Officer | S-Sale | D | Common Stock | 3,985 | 3.16 | 12.6K | 483,776 | — | ↗ |
| 2024-02-27 | Furlong Stephen | Officer | S-Sale | D | Common Stock | 21,272 | 3.33 | 70.8K | 487,761 | — | ↗ |
| 2024-02-26 | Sullivan Keith J | Director / Officer | S-Sale | D | Common Stock | 20,292 | 3.30 | 67.0K | 1,372,278 | — | ↗ |
| 2024-02-23 | Sullivan Keith J | Director / Officer | S-Sale | D | Common Stock | 20,750 | 3.23 | 67.0K | 1,392,570 | — | ↗ |
| 2024-02-22 | Sullivan Keith J | Director / Officer | S-Sale | D | Common Stock | 20,851 | 3.23 | 67.3K | 1,413,320 | — | ↗ |
| 2024-02-20 | Sullivan Keith J | Director / Officer | S-Sale | D | Common Stock | 23,958 | 2.96 | 70.9K | 1,434,171 | — | ↗ |
| 2024-02-14 | MACAN WILLIAM ANDREW | Officer | S-Sale | D | Common Stock | 15,621 | 3.38 | 52.8K | 417,736 | — | ↗ |
| 2024-02-09 | Furlong Stephen | Officer | S-Sale | D | Common Stock | 14,710 | 3.51 | 51.6K | 509,033 | — | ↗ |
| 2024-02-06 | MACAN WILLIAM ANDREW | Officer | S-Sale | D | Common Stock | 5,385 | 3.39 | 18.3K | 433,357 | — | ↗ |
| 2024-02-06 | Furlong Stephen | Officer | S-Sale | D | Common Stock | 5,813 | 3.39 | 19.7K | 523,743 | — | ↗ |
| 2024-02-05 | Sullivan Keith J | Director / Officer | A-Award | A | Common Stock | 300,000 | 0.00 | — | 1,458,129 | — | ↗ |
| 2024-02-05 | MACAN WILLIAM ANDREW | Officer | A-Award | A | Common Stock | 90,000 | 0.00 | — | 438,742 | — | ↗ |
| 2024-02-05 | Furlong Stephen | Officer | A-Award | A | Common Stock | 100,000 | 0.00 | — | 529,556 | — | ↗ |
| 2024-01-11 | Sullivan Keith J | Director / Officer | S-Sale | D | Common Stock | 9,516 | 3.16 | 30.1K | 1,158,129 | — | ↗ |
| 2024-01-10 | Sullivan Keith J | Director / Officer | S-Sale | D | Common Stock | 10,013 | 3.01 | 30.1K | 1,167,645 | — | ↗ |
| 2023-12-21 | MACAN WILLIAM ANDREW | Officer | S-Sale | D | Common Stock | 11,663 | 2.52 | 29.4K | 348,742 | — | ↗ |
| 2023-12-20 | MACAN WILLIAM ANDREW | Officer | S-Sale | D | Common Stock | 11,664 | 2.70 | 31.5K | 360,405 | — | ↗ |
| 2023-12-19 | MACAN WILLIAM ANDREW | Officer | S-Sale | D | Common Stock | 11,664 | 2.24 | 26.1K | 372,069 | — | ↗ |
| 2023-10-06 | MACAN WILLIAM ANDREW | Officer | S-Sale | D | Common Stock | 1,469 | 1.16 | 1.7K | 383,733 | — | ↗ |
| 2023-10-06 | Furlong Stephen | Officer | S-Sale | D | Common Stock | 1,499 | 1.16 | 1.7K | 429,556 | — | ↗ |
| 2023-08-10 | CASCELLA ROBERT | Director | P-Purchase | A | Common Stock | 28,500 | 1.81 | 51.7K | 162,848 | — | ↗ |
| 2023-07-21 | Sullivan Keith J | Director / Officer | S-Sale | D | Common Stock | 6,551 | 2.04 | 13.4K | 1,177,658 | — | ↗ |
| 2023-07-20 | Sullivan Keith J | Director / Officer | S-Sale | D | Common Stock | 6,510 | 2.06 | 13.4K | 1,184,209 | — | ↗ |
| 2023-07-19 | Sullivan Keith J | Director / Officer | S-Sale | D | Common Stock | 6,479 | 2.07 | 13.4K | 1,190,719 | — | ↗ |
| 2023-07-11 | MACAN WILLIAM ANDREW | Officer | S-Sale | D | Common Stock | 2,645 | 2.13 | 5.6K | 385,202 | — | ↗ |
| 2023-06-01 | CANNELL CAPITAL LLC | 10% Owner | J-Other | D | Neuronetics, Inc. Ordinary Stock | 286,596 | 0.00 | — | 2,841,223 | — | ↗ |
| 2023-05-25 | Rosengarten Megan | Director | A-Award | A | Common Stock | 36,364 | 0.00 | — | 85,890 | — | ↗ |
| 2023-05-25 | MUIR GLENN P | Director | A-Award | A | Common Stock | 36,364 | 0.00 | — | 164,647 | — | ↗ |
| 2023-05-25 | JAEGER WILFRED E | Director | A-Award | A | Common Stock | 36,364 | 0.00 | — | 138,563 | — | ↗ |
| 2023-05-25 | Capper Joseph H | Director | A-Award | A | Common Stock | 36,364 | 0.00 | — | 43,147 | — | ↗ |
| 2023-05-25 | CONLEY SHERYL L | Director | A-Award | A | Common Stock | 36,364 | 0.00 | — | 114,946 | — | ↗ |
| 2023-05-25 | CASCELLA ROBERT | Director | A-Award | A | Common Stock | 45,455 | 0.00 | — | 134,348 | — | ↗ |
| 2023-05-25 | BAKEWELL JOHN K | Director | A-Award | A | Common Stock | 36,364 | 0.00 | — | 114,352 | — | ↗ |
| 2023-05-24 | BAKEWELL JOHN K | Director | S-Sale | D | Common Stock | 14,400 | 2.70 | 38.9K | 77,988 | — | ↗ |
| 2023-03-17 | CANNELL CAPITAL LLC | 10% Owner | P-Purchase | A | Neuronetics, Inc. Ordinary Stock | 7,644 | 2.89 | 22.1K | 3,127,819 | — | ↗ |
| 2023-03-16 | CANNELL CAPITAL LLC | 10% Owner | P-Purchase | A | Neuronetics, Inc. Ordinary Stock | 52,072 | 2.90 | 151.0K | 3,120,175 | — | ↗ |
| 2023-03-13 | CANNELL CAPITAL LLC | 10% Owner | P-Purchase | A | Neuronetics, Inc. Ordinary Stock | 136,520 | 2.97 | 405.5K | 3,068,103 | — | ↗ |
| 2023-03-07 | MACAN WILLIAM ANDREW | Officer | S-Sale | D | Common Stock | 12,692 | 4.59 | 58.3K | 387,847 | — | ↗ |
| 2023-03-07 | Furlong Stephen | Officer | S-Sale | D | Common Stock | 11,079 | 4.59 | 50.9K | 431,055 | — | ↗ |
| 2023-03-07 | CANNELL CAPITAL LLC | 10% Owner | S-Sale | D | Neuronetics, Inc. Ordinary Stock | 7,746 | 4.71 | 36.5K | 2,931,583 | — | ↗ |
| 2023-02-16 | MACAN WILLIAM ANDREW | Officer | S-Sale | D | Common Stock | 11,044 | 5.91 | 65.3K | 400,539 | — | ↗ |
| 2023-02-15 | MACAN WILLIAM ANDREW | Officer | S-Sale | D | Common Stock | 11,974 | 5.90 | 70.6K | 411,583 | — | ↗ |
| 2023-02-15 | Furlong Stephen | Officer | S-Sale | D | Common Stock | 13,148 | 5.90 | 77.6K | 442,134 | — | ↗ |
| 2023-02-14 | Sullivan Keith J | Director / Officer | S-Sale | D | Common Stock | 13,647 | 5.58 | 76.2K | 1,197,198 | — | ↗ |
| 2023-02-14 | Furlong Stephen | Officer | S-Sale | D | Common Stock | 12,403 | 5.58 | 69.2K | 455,282 | — | ↗ |
| 2023-02-13 | Sullivan Keith J | Director / Officer | S-Sale | D | Common Stock | 25,154 | 5.49 | 138.1K | 1,210,845 | — | ↗ |
| 2023-02-09 | Sullivan Keith J | Director / Officer | A-Award | A | Common Stock | 285,000 | 0.00 | — | 1,235,999 | — | ↗ |
| 2023-02-08 | MACAN WILLIAM ANDREW | Officer | A-Award | A | Common Stock | 90,000 | 0.00 | — | 423,557 | — | ↗ |
| 2023-02-08 | Furlong Stephen | Officer | A-Award | A | Common Stock | 100,000 | 0.00 | — | 467,685 | — | ↗ |
| 2023-02-07 | MACAN WILLIAM ANDREW | Officer | S-Sale | D | Common Stock | 5,162 | 5.99 | 30.9K | 333,557 | — | ↗ |
| 2023-02-07 | Furlong Stephen | Officer | S-Sale | D | Common Stock | 5,584 | 5.99 | 33.4K | 367,685 | — | ↗ |
| 2023-01-23 | MACAN WILLIAM ANDREW | Officer | S-Sale | D | Common Stock | 16,046 | 5.96 | 95.6K | 338,719 | — | ↗ |
| 2023-01-17 | Furlong Stephen | Officer | S-Sale | D | Common Stock | 16,050 | 6.13 | 98.4K | 373,269 | — | ↗ |
| 2023-01-17 | CANNELL CAPITAL LLC | Director | S-Sale | D | Neuronetics, Inc. Ordinary Stock | 2,912 | 6.31 | 18.4K | 2,939,329 | — | ↗ |
| 2023-01-13 | CANNELL CAPITAL LLC | Director | S-Sale | D | Neuronetics, Inc. Ordinary Stock | 4,896 | 6.30 | 30.8K | 2,942,241 | — | ↗ |
| 2023-01-12 | CANNELL CAPITAL LLC | Director | S-Sale | D | Neuronetics, Inc. Ordinary Stock | 12,397 | 6.30 | 78.1K | 2,947,137 | — | ↗ |
| 2023-01-11 | CANNELL CAPITAL LLC | Director | S-Sale | D | Neuronetics, Inc. Ordinary Stock | 8,970 | 6.45 | 57.9K | 2,959,534 | — | ↗ |
| 2023-01-10 | CANNELL CAPITAL LLC | Director | S-Sale | D | Neuronetics, Inc. Ordinary Stock | 36,885 | 6.68 | 246.4K | 2,968,504 | — | ↗ |
| 2023-01-09 | CANNELL CAPITAL LLC | Director | S-Sale | D | Neuronetics, Inc. Ordinary Stock | 141,664 | 6.59 | 933.6K | 3,005,389 | — | ↗ |
| 2023-01-06 | CANNELL CAPITAL LLC | Director | S-Sale | D | Neuronetics, Inc. Ordinary Stock | 25,937 | 6.61 | 171.4K | 3,147,053 | — | ↗ |
| 2023-01-05 | CANNELL CAPITAL LLC | Director | S-Sale | D | Neuronetics, Inc. Ordinary Stock | 33,267 | 6.29 | 209.2K | 3,172,990 | — | ↗ |
| 2023-01-04 | CANNELL CAPITAL LLC | Director | S-Sale | D | Neuronetics, Inc. Ordinary Stock | 23,434 | 6.73 | 157.7K | 3,206,257 | — | ↗ |
| 2023-01-03 | CANNELL CAPITAL LLC | Director | S-Sale | D | Neuronetics, Inc. Ordinary Stock | 16,440 | 6.66 | 109.5K | 3,299,691 | — | ↗ |
| 2023-01-01 | Capper Joseph H | Director | — | D | Common Stock | 0 | 0.00 | — | 1,000 | — | ↗ |
| 2022-12-27 | CANNELL CAPITAL LLC | Director | S-Sale | D | Neuronetics, Inc. Ordinary Stock | 6,161 | 6.01 | 37.0K | 3,246,131 | — | ↗ |
| 2022-12-23 | CANNELL CAPITAL LLC | Director | S-Sale | D | Neuronetics, Inc. Ordinary Stock | 6,513 | 6.02 | 39.2K | 3,252,292 | — | ↗ |
| 2022-12-22 | CANNELL CAPITAL LLC | Director | S-Sale | D | Neuronetics, Inc. Ordinary Stock | 1,500 | 6.11 | 9.2K | 3,258,805 | — | ↗ |
| 2022-12-21 | CANNELL CAPITAL LLC | Director | S-Sale | D | Neuronetics, Inc. Ordinary Stock | 7,311 | 6.31 | 46.1K | 3,260,305 | — | ↗ |
| 2022-12-20 | CANNELL CAPITAL LLC | Director | S-Sale | D | Neuronetics, Inc. Ordinary Stock | 183,198 | 6.30 | 1.15M | 3,267,616 | — | ↗ |
| 2022-12-19 | CANNELL CAPITAL LLC | Director | S-Sale | D | Neuronetics, Inc. Ordinary Stock | 13,032 | 6.35 | 82.8K | 3,450,814 | — | ↗ |
| 2022-10-20 | Sullivan Keith J | Officer | M-Exempt | A | Common Stock | 100,000 | 1.98 | 198.0K | 950,999 | — | ↗ |
| 2022-10-11 | Furlong Stephen | Officer | S-Sale | D | Common Stock | 1,630 | 2.97 | 4.8K | 389,319 | — | ↗ |
| 2022-10-10 | MACAN WILLIAM ANDREW | Officer | S-Sale | D | Common Stock | 76 | 2.82 | 214.32 | 354,765 | — | ↗ |
| 2022-10-07 | MACAN WILLIAM ANDREW | Officer | S-Sale | D | Common Stock | 1,547 | 2.93 | 4.5K | 354,841 | — | ↗ |
| 2022-07-25 | Furlong Stephen | Officer | S-Sale | D | Common Stock | 13,321 | 3.54 | 47.2K | 390,949 | — | ↗ |
| 2022-07-18 | Sullivan Keith J | Officer | S-Sale | D | Common Stock | 63,466 | 3.72 | 236.1K | 850,999 | — | ↗ |
| 2022-07-08 | MACAN WILLIAM ANDREW | Officer | S-Sale | D | Common Stock | 2,746 | 3.60 | 9.9K | 356,388 | — | ↗ |
| 2022-06-16 | CANNELL CAPITAL LLC | 10% Owner | P-Purchase | A | Neuronetics, Inc. Ordinary Stock | 2,576 | 3.09 | 8.0K | 3,462,716 | — | ↗ |
| 2022-06-15 | CANNELL CAPITAL LLC | 10% Owner | P-Purchase | A | Neuronetics, Inc. Ordinary Stock | 1,364 | 3.57 | 4.9K | 3,460,140 | — | ↗ |
| 2022-06-13 | CANNELL CAPITAL LLC | 10% Owner | P-Purchase | A | Neuronetics, Inc. Ordinary Stock | 1,347 | 3.52 | 4.7K | 3,457,429 | — | ↗ |
| 2022-06-10 | CANNELL CAPITAL LLC | Director | P-Purchase | A | Neuronetics, Inc. Ordinary Stock | 1,347 | 3.57 | 4.8K | 3,458,776 | — | ↗ |
| 2022-06-01 | CANNELL CAPITAL LLC | Director | P-Purchase | A | Neuronetics, Inc. Ordinary Stock | 10,000 | 2.69 | 26.9K | 3,451,732 | — | ↗ |
| 2022-05-27 | CANNELL CAPITAL LLC | 10% Owner | P-Purchase | A | Neuronetics, Inc. Ordinary Stock | 300 | 2.56 | 768.00 | 3,433,396 | — | ↗ |
| 2022-05-26 | Shook Bruce Joseph | Director | A-Award | A | Common Stock | 38,910 | 0.00 | — | 68,847 | — | ↗ |
| 2022-05-26 | Rosengarten Megan | Director | A-Award | A | Common Stock | 38,910 | 0.00 | — | 49,526 | — | ↗ |
| 2022-05-26 | MUIR GLENN P | Director | A-Award | A | Common Stock | 38,910 | 0.00 | — | 128,271 | — | ↗ |
| 2022-05-26 | JAEGER WILFRED E | Director | A-Award | A | Common Stock | 38,910 | 0.00 | — | 102,187 | — | ↗ |
| 2022-05-26 | CONLEY SHERYL L | Director | A-Award | A | Common Stock | 38,910 | 0.00 | — | 78,582 | — | ↗ |
| 2022-05-26 | CASCELLA ROBERT | Director | A-Award | A | Common Stock | 48,638 | 0.00 | — | 88,893 | — | ↗ |
| 2022-05-26 | CANNELL CAPITAL LLC | Director | P-Purchase | A | Neuronetics, Inc. Ordinary Stock | 8,336 | 2.75 | 22.9K | 3,441,732 | — | ↗ |
| 2022-05-26 | BAKEWELL JOHN K | Director | A-Award | A | Common Stock | 38,910 | 0.00 | — | 92,388 | — | ↗ |
| 2022-05-25 | CANNELL CAPITAL LLC | 10% Owner | P-Purchase | A | Neuronetics, Inc. Ordinary Stock | 4,680 | 2.44 | 11.4K | 3,432,186 | — | ↗ |
| 2022-05-23 | CANNELL CAPITAL LLC | Director | P-Purchase | A | Neuronetics, Inc. Ordinary Stock | 4,831 | 2.34 | 11.3K | 3,427,506 | — | ↗ |
| 2022-05-19 | CANNELL CAPITAL LLC | 10% Owner | P-Purchase | A | Neuronetics, Inc. Ordinary Stock | 1,400 | 2.33 | 3.3K | 3,377,694 | — | ↗ |
| 2022-05-18 | CANNELL CAPITAL LLC | Director | P-Purchase | A | Neuronetics, Inc. Ordinary Stock | 15,369 | 2.41 | 37.0K | 3,393,063 | — | ↗ |
| 2022-05-10 | CANNELL CAPITAL LLC | Director | P-Purchase | A | Neuronetics, Inc. Ordinary Stock | 106,455 | 2.13 | 226.7K | 3,329,150 | — | ↗ |
| 2022-05-09 | CANNELL CAPITAL LLC | 10% Owner | P-Purchase | A | Neuronetics, Inc. Ordinary Stock | 7,094 | 2.31 | 16.4K | 3,207,504 | — | ↗ |
| 2022-05-06 | CANNELL CAPITAL LLC | 10% Owner | P-Purchase | A | Neuronetics, Inc. Ordinary Stock | 10,000 | 2.42 | 24.2K | 3,200,410 | — | ↗ |
| 2022-05-05 | CANNELL CAPITAL LLC | Director | P-Purchase | A | Neuronetics, Inc. Ordinary Stock | 8,056 | 2.44 | 19.7K | 3,190,410 | — | ↗ |
| 2022-05-04 | CANNELL CAPITAL LLC | 10% Owner | P-Purchase | A | Neuronetics, Inc. Ordinary Stock | 20,000 | 2.47 | 49.4K | 3,182,354 | — | ↗ |
| 2022-05-03 | CANNELL CAPITAL LLC | 10% Owner | P-Purchase | A | Neuronetics, Inc. Ordinary Stock | 15,000 | 2.53 | 38.0K | 3,162,354 | — | ↗ |
| 2022-05-02 | CANNELL CAPITAL LLC | Director | P-Purchase | A | Neuronetics, Inc. Ordinary Stock | 5,429 | 2.48 | 13.5K | 3,147,354 | — | ↗ |
| 2022-04-26 | CANNELL CAPITAL LLC | 10% Owner | P-Purchase | A | Neuronetics, Inc. Ordinary Stock | 7,547 | 2.70 | 20.4K | 3,141,925 | — | ↗ |
| 2022-04-22 | CANNELL CAPITAL LLC | 10% Owner | P-Purchase | A | Neuronetics, Inc. Ordinary Stock | 1,555 | 2.85 | 4.4K | 3,132,674 | — | ↗ |
| 2022-04-19 | CANNELL CAPITAL LLC | Director | P-Purchase | A | Neuronetics, Inc. Ordinary Stock | 206 | 2.89 | 595.34 | 3,131,119 | — | ↗ |
| 2022-04-12 | CANNELL CAPITAL LLC | 10% Owner | P-Purchase | A | Neuronetics, Inc. Ordinary Stock | 75,919 | 2.95 | 224.0K | 3,097,513 | — | ↗ |
| 2022-04-11 | CANNELL CAPITAL LLC | Director | P-Purchase | A | Neuronetics, Inc. Ordinary Stock | 33,400 | 2.88 | 96.2K | 3,130,913 | — | ↗ |
| 2022-04-06 | CANNELL CAPITAL LLC | Director | P-Purchase | A | Neuronetics, Inc. Ordinary Stock | 2,829 | 3.16 | 8.9K | 2,996,594 | — | ↗ |
| 2022-04-01 | CANNELL CAPITAL LLC | 10% Owner | P-Purchase | A | Neuronetics, Inc. Ordinary Stock | 243,412 | 3.00 | 730.2K | 2,993,765 | — | ↗ |
| 2022-03-31 | CANNELL CAPITAL LLC | Director | P-Purchase | A | Neuronetics, Inc. Ordinary Stock | 21,893 | 2.99 | 65.5K | 2,750,353 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-43.9K
Shares Outstanding
69.58M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Keith J. Sullivan President and Chief Executive Officer | 728.0K | — | 3.21M | — | 412.8K | 15.5K | 4.37M | 73.51% | ↗ |
| 2 | 2025 | Steven E. Pfanstiel, Executive Vice President, Chief Financial Officer, and Treasurer | 221.8K | 27.9K | 2.04M | — | 45.3K | — | 2.33M | 87.35% | ↗ |
| 3 | 2025 | W. Andrew Macan Executive Vice President, Chief Legal Officer, and Corporate Secretary | 463.5K | 69.5K | 1.46M | — | 93.9K | 25.7K | 2.11M | 69.14% | ↗ |
| 4 | 2025 | Stephen Furlong, Executive Vice President, Chief Financial Officer , and Treasurer | 281.9K | — | 936.6K | — | — | — | 1.22M | 76.87% | ↗ |
| 5 | 2024 | Keith J. Sullivan President and Chief Executive Officer | 728.0K | — | 1.50M | — | 169.3K | 30.4K | 2.43M | 61.84% | ↗ |
| 6 | 2024 | Stephen Furlong, Executive Vice President, Chief Financial Officer | 466.1K | 46.6K | 546.0K | — | 54.2K | 69.3K | 1.18M | 46.19% | ↗ |
| 7 | 2024 | Stephen Furlong, Executive Vice President, Chief Financial Officer , and Treasurer | 446.1K | 46.6K | 546.0K | — | 54.2K | 69.3K | 1.18M | 46.19% | ↗ |
| 8 | 2024 | W. Andrew Macan Executive Vice President, Chief Legal Officer, and Corporate Secretary | 450.0K | 45.0K | 512.2K | — | 52.3K | — | 1.06M | 48.34% | ↗ |
| 9 | 2024 | W. Andrew Macan Executive Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary | 450.0K | 45.0K | 512.2K | — | 52.3K | — | 1.06M | 48.34% | ↗ |
| 10 | 2023 | Keith J. Sullivan President and Chief Executive Officer | 700.0K | — | 1.60M | — | 660.8K | 28.5K | 2.99M | 53.55% | ↗ |
| 11 | 2023 | Stephen Furlong, Executive Vice President, Chief Financial Officer | 448.2K | 56.0K | 590.0K | — | 170.3K | 96.8K | 1.36M | 43.34% | ↗ |
| 12 | 2023 | W. Andrew Macan Executive Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary | 409.4K | 51.2K | 531.0K | — | 155.6K | 13.6K | 1.16M | 45.75% | ↗ |
| 13 | 2022 | Keith J. Sullivan President and Chief Executive Officer | 676.0K | — | 900.0K | — | 841.6K | 34.6K | 2.45M | 36.70% | ↗ |
| 14 | 2022 | Stephen Furlong, Executive Vice President, Chief Financial Officer | 431.0K | 53.9K | 560.0K | — | 223.0K | 102.3K | 1.37M | 40.87% | ↗ |
| 15 | 2022 | W. Andrew Macan Executive Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary | 393.6K | 49.2K | 528.0K | — | 203.7K | — | 1.17M | 44.95% | ↗ |
| 16 | 2021 | Keith J. Sullivan President and Chief Executive Officer | 650.0K | 585.0K | 1.59M | — | — | 11.7K | 2.84M | 56.08% | ↗ |
| 17 | 2021 | Stephen Furlong, Executive Vice President, Chief Financial Officer | 414.4K | 186.5K | 1.18M | — | — | 79.1K | 1.86M | 63.45% | ↗ |
| 18 | 2021 | Stephen Furlong, Senior Vice President, Chief Financial Officer | 414.4K | 186.5K | 1.18M | — | — | 79.1K | 1.86M | 63.45% | ↗ |
| 19 | 2021 | W. Andrew Macan Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary | 378.5K | 170.3K | 750.3K | — | — | — | 1.30M | 57.75% | ↗ |
| 20 | 2021 | W. Andrew Macan Executive Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary | 378.5K | 170.3K | 750.3K | — | — | — | 1.30M | 57.75% | ↗ |
| 21 | 2020 | Keith J. Sullivan President and Chief Executive Officer | 279.6K | 225.0K | 1.98M | 1.08M | — | 6.2K | 3.57M | 85.68% | ↗ |
| 22 | 2020 | Christopher A. Thatcher, Former President and Chief Executive Officer | 180.4K | — | 728.0K | — | — | 505.5K | 1.41M | 51.49% | ↗ |
| 23 | 2020 | W. Andrew Macan Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary | 407.9K | — | 682.1K | — | 150.1K | 111.3K | 1.35M | 50.47% | ↗ |
| 24 | 2020 | Stephen Furlong, Senior Vice President, Chief Financial Officer | 436.0K | — | 572.0K | — | 200.6K | 65.1K | 1.27M | 44.91% | ↗ |
| 25 | 2020 | Stephen Furlong, Vice President, Chief Financial Officer | 436.0K | — | 572.0K | — | 200.6K | 65.1K | 1.27M | 44.91% | ↗ |
| 26 | 2020 | Daniel Guthrie, Former Chief Commercial Officer | 331.0K | — | 307.0K | — | 137.0K | 31.8K | 806.9K | 38.05% | ↗ |
| 27 | 2020 | Gregory Harper, Former Vice President, R&D and Clinical | 342.0K | — | 266.2K | — | 110.1K | — | 718.3K | 37.06% | ↗ |
| 28 | 2019 | Christopher A. Thatcher, Former President and Chief Executive Officer | 535.0K | — | 900.0K | 839.6K | 345.9K | — | 2.62M | 66.38% | ↗ |
| 29 | 2019 | Stephen Furlong, Vice President, Chief Financial Officer | 156.6K | — | 700.0K | 720.0K | 136.3K | 45.3K | 1.76M | 80.77% | ↗ |
| 30 | 2019 | Gregory Harper, Vice President, Product Development and Operations | 330.0K | — | 325.6K | 176.2K | 105.1K | — | 945.7K | 53.07% | ↗ |
| 31 | 2019 | Gregory Harper, Former Vice President, R&D and Clinical | 330.0K | — | 325.6K | 176.2K | 105.1K | — | 936.9K | 53.56% | ↗ |
| 32 | 2019 | Daniel Guthrie, Former Chief Commercial Officer | 323.0K | — | 140.0K | 133.4K | 106.1K | — | 702.5K | 38.91% | ↗ |
| 33 | 2018 | Dan Guthrie, Vice President and Chief Commercial Officer | 182.9K | — | 953.6K | 627.5K | 104.1K | 69.0K | 1.94M | 81.62% | ↗ |
| 34 | 2018 | Christopher A. Thatcher, Former President and Chief Executive Officer | 475.0K | — | — | 274.4K | 430.1K | — | 1.18M | 23.27% | ↗ |
| 35 | 2018 | Christopher A. Thatcher, President and Chief Executive Officer | 475.0K | — | — | 274.4K | 430.1K | — | 1.18M | 23.27% | ↗ |
| 36 | 2018 | Yelena Tropsha, Vice President, Commercial Access Medical Operations | 294.5K | — | — | 239.7K | 117.9K | 86.1K | 738.2K | 32.47% | ↗ |
| 37 | 2017 | Christopher A. Thatcher, President and Chief Executive Officer | 400.2K | — | — | 118.7K | 240.1K | — | 759.0K | 15.64% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Keith J. Sullivan | President, Chief Executive Officer & Director | 927.6K | male |
| Daniel L. Reuvers | President, Chief Executive Officer & Director | 927.6K | male |
| W. Andrew Macan | EVice President, Chief Legal Officer & Corporate Secretary | 652.5K | male |
| Stephen J. Furlong | Senior Advisor to the Chief Executive Officer | 636.2K | male |
| Steven E. Pfanstiel | Executive Vice President, Treasurer & Chief Financial Officer | 557.2K | male |
| Lisa Metzner-Rosas | Senior Vice President & Chief Marketing Officer | — | female |
| Jeffrey S. Jones | Senior Vice President & Chief of Operations | — | male |
| Cory S. Anderson | SVP & Chief Technology Officer | — | male |
ESG Rating
ESG Score History MEDICAL - DIAGNOSTICS & RESEARCH
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for STIM
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
